<?xml version="1.0" encoding="UTF-8"?>
<p>The cytotoxicity was evaluated by the [3H] thymidine assay using breast cancer (MCF-7) and colon cancer (COLO-205) cell lines. Doxorubicin (10 µg), was used as a positive control with ED
 <sub>50</sub> (50% effective dose) value of 1.8 µg/mL against MCF-7 cell line. Compound 
 <bold>362</bold> showed cytotoxic activity against MCF-7 cell line with ED
 <sub>50</sub> value of &gt;10 µg/mL [
 <xref rid="B116-ijms-22-00959" ref-type="bibr">116</xref>].
</p>
